A CFTR result needs more than a gene symbol and a label. The useful questions are which change was found, how it was described, what the laboratory tested, and how the finding relates to the person’s clinical question. This guide provides a structured reading method for students, researchers and people preparing to discuss a report.
In this guide: What does the CFTR gene do? · Read the report in five passes · Why “two variants” is not the complete answer · How to investigate a database result · Does a CFTR finding tell me which treatment will work? · A practical worksheet · Common question: does one negative result exclude every CFTR disorder?
What does the CFTR gene do?
CFTR encodes a membrane channel involved in chloride transport and fluid balance. Different variants can affect protein production, processing or channel function. The commonly discussed F508del variant removes phenylalanine at position 508 and disrupts normal protein processing. A familiar protein nickname is useful for communication, but the laboratory’s full sequence description is needed to match records precisely. [1]
The same gene can be relevant to cystic fibrosis and to more limited CFTR-related presentations. Gene-level relevance therefore does not automatically establish a particular person’s diagnosis. Start with the companion cystic fibrosis guide if the main question concerns symptoms, sweat testing or family counseling. [2]
Read the report in five passes
- Purpose and sample. Write down whether the test was carrier screening, diagnostic testing or follow-up of a known family finding. Record the specimen and laboratory.
- Exact identity. Copy the transcript accession and version, the DNA-level description and any protein-level description. Retain the original report; do not silently remove punctuation or version numbers.
- Gene copies. Record zygosity: was the change found in one or both copies? If two different variants appear, does the report establish their phase—their arrangement across the two gene copies?
- Classification and scope. Note the laboratory’s classification, the condition to which it applies and the report date. Separate a variant classification from the overall clinical conclusion.
- Limitations and next step. Ask whether the assay evaluated relevant sequence changes and deletions/duplications, and which important regions or variant types could remain unresolved.
ACMG’s CFTR technical standard addresses the differences between testing strategies and the need for appropriate variant interpretation. A screening panel and a more extensive diagnostic assay should not be assumed to have identical scope. [3]
Why “two variants” is not the complete answer
For an autosomal recessive explanation, findings on opposite gene copies—in trans—have a different meaning from two findings on the same copy—in cis. Family testing can sometimes resolve that arrangement. Phase is one part of interpretation; it does not make an uncertain variant pathogenic. [3]
Illustrative reading example: imagine a report listing two sequence changes but saying “phase unknown.” A careful summary is “two findings were reported; their arrangement and clinical interpretation need clarification.” It is not “both copies are definitely affected.” This example is a reasoning exercise, not a real patient’s result or a diagnosis.
How to investigate a database result
Open the variant research assistant and enter the gene plus the exact non-identifying variant description. On ClinVar, check that the record matches the variant and condition. Read the review status, evaluation dates and underlying submissions. ClinVar’s stars describe review status, not the probability that an individual will develop disease. [4]
Record agreement and disagreement separately. A long list of submissions is not a substitute for understanding their evidence. Our articles on ClinVar discordance and the ACMG/AMP framework explain why a database summary should not be used as an automatic diagnosis.
A variant of uncertain significance means the evidence is insufficient for a confident clinical classification. It should not be rewritten as “probably the cause” simply because the gene fits the symptoms. Ask the reporting laboratory or genetics professional what evidence could resolve uncertainty and whether reanalysis is appropriate. [5]
Does a CFTR finding tell me which treatment will work?
CFTR modulators target certain protein defects; different medicines and combinations have different eligibility requirements. A variant being disease-causing does not itself establish that every modulator will help. Current approved indications, age, interactions and monitoring belong in a discussion with the treating CF team. Experimental cell responses and trial eligibility are further, separate questions. [6]
When reading research, make a small evidence table: model used; variant tested; measurement of channel function; comparison group; repeat experiments; and any clinical outcomes. Ask whether the experiment tested the same molecular change and whether the result was replicated. Read functional variant assays before equating an abnormal laboratory signal with a clinical prediction.
A practical worksheet
- My question: carrier status, diagnosis, family testing or treatment research?
- Exact variant, transcript/version and phase: recorded or unresolved?
- Laboratory classification, date and condition: copied accurately?
- Evidence source: original study, expert assessment or unreviewed assertion?
- What additional information would change the conclusion?
- Which question should go back to the laboratory or CF specialist?
Use the literature search builder for a documented search and the care finder for professional support. Do not enter names, full medical records or identifying details into search tools.
Common question: does one negative result exclude every CFTR disorder?
No single word such as “negative” states a test’s coverage. Read the methods and limitations alongside the clinical question, and use our testing blind spots guide. A professional may decide that no further testing is needed, or that a different investigation is justified; this checklist cannot make that decision.
Educational information. No individual variant classification or treatment recommendation is generated here.